Sub-millimetric, patient-specific brain targeting for functional neurosurgery and real-world outcomes in Parkinson’s Disease and Essential Tremor.

“La Gazette du Laboratoire” Features RebrAIn’s Breakthrough in Deep Brain Stimulation

We are pleased to announce that La Gazette du Laboratoire has featured RebrAIn for our revolutionary advancements in neurosurgical targeting for Deep Brain Stimulation (DBS).

The article highlights our collaboration with SATT Aquitaine Science Transfert and the development of our supervised AI-driven platform, OptimDBS, designed to enhance the precision and effectiveness of DBS treatments.

Learn more about how RebrAIn is transforming neurosurgery and improving patient outcomes by reading the full article here, in french.

An English translation by Google is available here.

Our latest public updates

Rebrain at WSSFN 2026

Rebrain at WSSFN 2026

Rebrain will take part in the 2026 World Society for Stereotactic and Functional Neurosurgery Congress (WSSFN), held at the Palais du Pharo in Marseille from September 30 to October 3. You will find the team, in the exhibition foyer next to the main entrance. Born...

Rebrain x Worldwide Dystonia Research Center

Rebrain x Worldwide Dystonia Research Center

Partnership aims to develop next-generation data-driven models for personalized deep brain stimulation (DBS) targeting, expanding clinical applications from Parkinson’s disease and essential tremor to dystonia and severe pediatric dystonia with global scalability...